{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T15:44:21Z","timestamp":1720107861510},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.gene.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,4,6]],"date-time":"2019-04-06T22:19:02Z","timestamp":1554589142000},"page":"112-119","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Correlation of CYP2D6 allelic polymorphism to outcome of acute coronary syndrome in mid-Euphrates Iraqi patients on metoprolol therapy"],"prefix":"10.1016","volume":"703","author":[{"given":"Asma A.","family":"Swadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassim I.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najah R.","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayder A.","family":"Al-Aubaidy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2019.04.012_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010104","article-title":"Pharmacogenetic foundations of therapeutic efficacy and adverse events of statins","volume":"18","author":"Arrigoni","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2019.04.012_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s13318-014-0205-x","article-title":"A metoprolol-terbinafine combination induced bradycardia","volume":"40","author":"Bebawi","year":"2015","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.gene.2019.04.012_bb0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/clpt.2013.96","article-title":"A meta-analysis of CYP2D6 metabolizer phenotype and metoprolol pharmacokinetics","volume":"94","author":"Blake","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.gene.2019.04.012_bb0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/gim.2016.87","article-title":"Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)","volume":"19","author":"Caudle","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2019.04.012_bb0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.21037\/atm.2016.05.10","article-title":"The clinics of acute coronary syndrome","volume":"4","author":"Cervellin","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.gene.2019.04.012_bb0030","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/1440-1681.12978","article-title":"Cytochrome P450 genotype-guided drug therapies: an update on current states","volume":"45","author":"Dong","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.gene.2019.04.012_bb0035","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s11033-018-4419-x","article-title":"Genetic variability among Mexican Mestizo and Amerindian populations based on three ABCB1 polymorphisms","volume":"45","author":"Favela-Mendoza","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.gene.2019.04.012_bb0040","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/sj.ejhg.5201243","article-title":"Molecular diversity at the CYP2D6 locus in the Mediterranean region","volume":"12","author":"Fuselli","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.gene.2019.04.012_bb0045","first-page":"243","article-title":"Acute coronary syndrome","volume":"73","author":"Gach","year":"2018","journal-title":"Rev. Med. Liege"},{"key":"10.1016\/j.gene.2019.04.012_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/gim.2016.80","article-title":"Prediction of CYP2D6 phenotype from genotype across world populations","volume":"19","author":"Gaedigk","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.gene.2019.04.012_bb0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0378-4347(84)80025-0","article-title":"Determination of two metoprolol metabolites in human urine by high-performance liquid chromatography","volume":"309","author":"Godbillon","year":"1984","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.gene.2019.04.012_bb0060","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00228-008-0525-3","article-title":"CYP2D6 is a major determinant of metoprolol disposition and effects in hospitalized Russian patients treated for acute myocardial infarction","volume":"64","author":"Goryachkina","year":"2008","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2019.04.012_bb0065","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.pharmthera.2007.09.004","article-title":"Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects","volume":"116","author":"Ingelman-Sundberg","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.gene.2019.04.012_bb0070","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2710.2006.00699.x","article-title":"The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients","volume":"31","author":"Ismail","year":"2006","journal-title":"J. Clin. Pharm. Ther."},{"key":"10.1016\/j.gene.2019.04.012_bb0075","first-page":"452","article-title":"Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation","volume":"46","author":"Johansson","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.gene.2019.04.012_bb0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/gtmb.2009.0009","article-title":"Frequency of five important CYP2D6 alleles within an Iranian population (Eastern Azerbaijan)","volume":"13","author":"Kouhi","year":"2009","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.gene.2019.04.012_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2125.2000.00209.x","article-title":"Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes","volume":"50","author":"Kubota","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2019.04.012_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1515\/bjmg-2015-0086","article-title":"CYP2D6 allele distribution in Macedonians, Albanians and Romanies in the Republic of Macedonia","volume":"18","author":"Kuzmanovska","year":"2016","journal-title":"Balkan J. Med. Genet."},{"key":"10.1016\/j.gene.2019.04.012_bb0095","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/clpt.2013.103","article-title":"Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing","volume":"94","author":"Leckband","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.gene.2019.04.012_bb0100","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1389200217666151105125425","article-title":"Impact of CYP2D6 genetic variation on the response of the cardiovascular patient to carvedilol and metoprolol","volume":"17","author":"Lymperopoulos","year":"2015","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.gene.2019.04.012_bb0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2125.1985.tb05112.x","article-title":"Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies","volume":"20","author":"McGourty","year":"1985","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2019.04.012_bb0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-199706000-00003","article-title":"Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians","volume":"7","author":"McLellan","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.gene.2019.04.012_bb0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/cbf.1258","article-title":"Characterization of variant alleles of cytochrome CYP2D6 in a Spanish population","volume":"24","author":"Menoyo","year":"2006","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.gene.2019.04.012_bb0120","first-page":"83","article-title":"Novel +90G>A intronic polymorphism of CYP2D6","volume":"17","author":"Modaresi-Nejad","year":"2015","journal-title":"Cell J."},{"key":"10.1016\/j.gene.2019.04.012_bb0125","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/ALN.0b013e3182315eb2","article-title":"Genetic variation, \u03b2-blockers, and perioperative myocardial infarction","volume":"115","author":"Nagele","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.gene.2019.04.012_bb0130","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1248\/bpb.29.1655","article-title":"CYP2D6 genetic polymorphism in South Indian populations","volume":"29","author":"Naveen","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.gene.2019.04.012_bb0135","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/jphp.12109","article-title":"Metoprolol oxidation polymorphism in Brazilian elderly cardiac patients","volume":"65","author":"Neves","year":"2013","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.gene.2019.04.012_bb0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/clpt.2008.218","article-title":"Impact of the CYP2D6 genotype on the clinical effects of metoprolol: a prospective longitudinal study","volume":"85","author":"Rau","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.gene.2019.04.012_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/FPC.0000000000000363","article-title":"CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels","volume":"29","author":"Ray","year":"2019","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.gene.2019.04.012_bb0150","first-page":"284","article-title":"Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences","volume":"60","author":"Sachse","year":"1997","journal-title":"Am. J. Hum. Genet."},{"issue":"28 Suppl","key":"10.1016\/j.gene.2019.04.012_bb0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00543716","article-title":"Polymorphic metabolism of metoprolol: clinical studies","author":"Silas","year":"1985","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.gene.2019.04.012_bb0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jep.2019.02.011","article-title":"PKA\/beta2-AR-Gs\/Gi signaling pathway is associated with anti-inflammatory and pro-apoptotic effects of Fuzi and Banxia combination on rats subjected to pressure overload","volume":"235","author":"Sun","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.gene.2019.04.012_bb0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/CIRCRESAHA.118.314576","article-title":"Overview of therapeutic approaches for cholesterol lowering and attenuation of thrombosis for prevention of atherothrombosis","volume":"124","author":"Weitz","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.gene.2019.04.012_bb0170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PAF.0000000000000447","article-title":"Supervised classification of CYP2D6 genotype and metabolizer phenotype with postmortem tramadol-exposed finns","volume":"40","author":"Wendt","year":"2019","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.gene.2019.04.012_bb0175","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jchromb.2013.08.017","article-title":"Determination of metoprolol and its two metabolites in human plasma and urine by high performance liquid chromatography with fluorescence detection and its application in pharmacokinetics","volume":"937","author":"Xu","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.gene.2019.04.012_bb0180","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/chromsci\/48.8.613","article-title":"Development and validation of GC-MS method for determination of metoprolol in human urine","volume":"48","author":"Yilmaz","year":"2010","journal-title":"J. Chromatogr. Sci."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919303518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919303518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T17:25:20Z","timestamp":1607189120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111919303518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":36,"alternative-id":["S0378111919303518"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2019.04.012","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of CYP2D6 allelic polymorphism to outcome of acute coronary syndrome in mid-Euphrates Iraqi patients on metoprolol therapy","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}